{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:28:30Z","timestamp":1793824110245,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>According to current definitions of Polycystic Ovary Syndrome (PCOS), hyperandrogenism is considered as a key element in the pathogenesis of this common endocrinopathy. However, until now, studies about ovarian androgen profile in women are very rare. Our aim was then to characterise the expression profile of the androgens in follicular fluid of 30 PCOS patients, and compare it to those of 47 Control women and 29 women with only polycystic ovary morphology on ultrasounds (ECHO group).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective, single-centre cohort study was performed. The intrafollicular concentrations of the key androgens were assessed and correlated with the intrafollicular levels of some adipokines of interest. Androgens were quantified by mass spectrophotometry combined with ultra-high-performance liquid chromatography, while adipokine concentrations were measured by ELISA assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In PCOS patients, the intrafollicular concentrations of the androgens synthesised by ovarian theca cells, i.e., 17OH-pregnenolone, dehydroepiandrosterone, \u03944-androstenedione and testosterone, were significantly higher than those of the androgens of adrenal origin, and positively correlated with the main PCOS clinical and biological features, as well as with the adipokines mostly expressed in the follicular fluid of PCOS patients, i.e. resistin, omentin, chemerin and apelin. Conversely, Control women showed the highest levels of 17OH-progesterone, deoxycorticosterone and 11-deoxycortisol. Confirming these results, apelin levels were negatively associated with pregnenolone and deoxycorticosterone concentrations, while visfatin levels, which were higher in the Control group, negatively correlated with the \u03944-androstenedione and testosterone ones.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PCOS is characterised by a selective increase in the intrafollicular levels of the androgens synthesised by theca cells, strengthening the hypothesis that ovarian hyperandrogenism plays a central role in its pathogenesis. Further, the significant correlation between the intrafollicular concentrations of the androgens and most of the adipokines of interest, including apelin, chemerin, resistin and omentin, confirms the existence of a close relationship between these two hormonal systems, which appear deeply involved in ovarian physiology and PCOS physiopathology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-022-00959-6","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T07:03:01Z","timestamp":1655190181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["High androgen concentrations in follicular fluid of polycystic ovary syndrome women"],"prefix":"10.1186","volume":"20","author":[{"given":"Alice","family":"Bongrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Plotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namya","family":"Mellouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Ram\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Guerif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Froment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00eblle","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"issue":"9","key":"959_CR1","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome\u2020\u2021. Hum Reprod. 2018;33(9):1602\u201318.","journal-title":"Hum Reprod"},{"issue":"1","key":"959_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41\u20137.","journal-title":"Hum Reprod"},{"issue":"2","key":"959_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"1","key":"959_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2265.1997.2321049.x","volume":"47","author":"C Gilling-Smith","year":"1997","unstructured":"Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol. 1997;47(1):93\u20139.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"959_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian Hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520.","journal-title":"Endocr Rev"},{"issue":"6","key":"959_CR6","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1210\/mend.13.6.0311","volume":"13","author":"VL Nelson","year":"1999","unstructured":"Nelson VL, Legro RS, Strauss JF, McAllister JM. Augmented androgen production is a stable Steroidogenic phenotype of propagated Theca cells from polycystic ovaries. Mol Endocrinol. 1999;13(6):946\u201357.","journal-title":"Mol Endocrinol"},{"key":"959_CR7","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Molecular Metabolism. 2020;35:100937.","journal-title":"Molecular Metabolism"},{"issue":"7","key":"959_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1042\/CS20171394","volume":"132","author":"X Wang","year":"2018","unstructured":"Wang X, Wang H, Liu W, Zhang Z, Zhang Y, Zhang W, et al. High level of C-type natriuretic peptide induced by hyperandrogen-mediated anovulation in polycystic ovary syndrome mice. Clin Sci. 2018;132(7):759\u201376.","journal-title":"Clin Sci"},{"issue":"8","key":"959_CR9","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/imj.12495","volume":"44","author":"S Shorakae","year":"2014","unstructured":"Shorakae S, Boyle J, Teede H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about: what a physician should know about PCOS. Intern Med J. 2014;44(8):720\u20136.","journal-title":"Intern Med J"},{"issue":"3","key":"959_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1530\/EC-18-0077","volume":"7","author":"D Glintborg","year":"2018","unstructured":"Glintborg D, Altinok ML, Ravn P, Stage KB, H\u00f8jlund K, Andersen M. Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS. Endocrine Connections. 2018;7(3):479\u201389.","journal-title":"Endocrine Connections"},{"key":"959_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms20184431","volume":"20","author":"A Estienne","year":"2019","unstructured":"Estienne A, Bongrani A, Reverchon M, Ram\u00e9 C, Ducluzeau PH, Froment P, et al. Involvement of novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in reproductive functions in Normal and pathological conditions in humans and animal models. Int J Mol Sci. 2019;20:18.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"959_CR12","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1007\/s43032-021-00709-w","volume":"28","author":"S Mehrabani","year":"2021","unstructured":"Mehrabani S, Arab A, Karimi E, Nouri M, Mansourian M. Blood circulating levels of Adipokines in polycystic ovary syndrome patients: a systematic review and Meta-analysis. Reprod Sci. 2021;28(11):3032\u201350.","journal-title":"Reprod Sci"},{"issue":"13","key":"959_CR13","doi-asserted-by":"publisher","first-page":"845165","DOI":"10.3389\/fendo.2022.845165","volume":"9","author":"Y Peng","year":"2022","unstructured":"Peng Y, Yang H, Song J, Feng D, Na Z, Jiang H, et al. Elevated serum Leptin levels as a predictive marker for polycystic ovary syndrome. Front Endocrinol. 2022;9(13):845165.","journal-title":"Front Endocrinol"},{"key":"959_CR14","first-page":"7","volume":"20","author":"A Barbe","year":"2019","unstructured":"Barbe A, Bongrani A, Mellouk N, Estienne A, Kurowska P, Grandhaye J, et al. Mechanisms of Adiponectin action in fertility: an overview from gametogenesis to gestation in humans and animal models in Normal and pathological conditions. Int J Mol Sci. 2019;20:7.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"959_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2337\/db11-1136","volume":"61","author":"KJ McInnes","year":"2012","unstructured":"McInnes KJ, Smith LB, Hunger NI, Saunders PTK, Andrew R, Walker BR. Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. Diabetes. 2012;61(5):1072\u201381.","journal-title":"Diabetes."},{"issue":"11","key":"959_CR16","doi-asserted-by":"publisher","first-page":"537809","DOI":"10.3389\/fendo.2020.537809","volume":"7","author":"K Lin","year":"2021","unstructured":"Lin K, Sun X, Wang X, Wang H, Chen X. Circulating Adipokine levels in nonobese women with polycystic ovary syndrome and in nonobese control women: a systematic review and Meta-analysis. Front Endocrinol. 2021;7(11):537809.","journal-title":"Front Endocrinol"},{"key":"959_CR17","doi-asserted-by":"publisher","first-page":"105806","DOI":"10.1016\/j.jsbmb.2020.105806","volume":"206","author":"Z Yang","year":"2021","unstructured":"Yang Z, Zhou W, Zhou C, Zhou Y, Liu X, Ding G, et al. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2021;206:105806.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"959_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/humupd\/dmt061","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, et al. Definition and significance of polycystic ovarian morphology: a task force report from the androgen excess and polycystic ovary syndrome society. Hum Reprod Update. 2014;20(3):334\u201352.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"959_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1472-6483(10)61275-8","volume":"9","author":"F Guerif","year":"2004","unstructured":"Guerif F, Saussereau MH, Barthelemy C, Couet ML, Gervereau O, Lansac J, et al. Efficacy of IVF using frozen donor semen in cases of previously failed DI cycles compared with tubal infertility: a cohort study. Reprod BioMed Online. 2004;9(4):404\u20138.","journal-title":"Reprod BioMed Online"},{"key":"959_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cca.2015.05.007","volume":"447","author":"C Meunier","year":"2015","unstructured":"Meunier C, Blondelle D, Faure P, Baguet JP, Le Goff C, Chabre O, et al. Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS\/MS. Clin Chim Acta. 2015;447:8\u201315.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"959_CR21","first-page":"70","volume":"73","author":"D Dufour-Rainfray","year":"2015","unstructured":"Dufour-Rainfray D, Moal V, Cloix L, Mathieu E, Gauchez AS, Brossaud J, et al. Mass spectrometry for steroid assays. Ann Biol Clin. 2015 Jan;73(1):70\u20138.","journal-title":"Ann Biol Clin"},{"issue":"1","key":"959_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-020-03576-x","volume":"78","author":"MSB Silva","year":"2021","unstructured":"Silva MSB, Giacobini P. New insights into anti-M\u00fcllerian hormone role in the hypothalamic\u2013pituitary\u2013gonadal axis and neuroendocrine development. Cell Mol Life Sci. 2021;78(1):1\u201316.","journal-title":"Cell Mol Life Sci"},{"key":"959_CR23","doi-asserted-by":"crossref","unstructured":"Bongrani A, Mellouk N, Rame C, Cornuau M, Gu\u00e9rif F, Froment P, et al. Ovarian expression of Adipokines in polycystic ovary syndrome: a role for Chemerin, Omentin, and Apelin in follicular growth arrest and ovulatory dysfunction? Int J Mol Sci. 2019;20(15).","DOI":"10.3390\/ijms20153778"},{"issue":"1","key":"959_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1530\/JOE-20-0550","volume":"249","author":"A Bongrani","year":"2021","unstructured":"Bongrani A, Mellouk N, Ram\u00e9 C, Cornuau M, Guerif F, Froment P, et al. Vaspin, a novel adipokine in woman granulosa cells physiology and PCOS pathogenesis? J Endocrinol. 2021;249(1):57\u201370.","journal-title":"J Endocrinol"},{"issue":"6","key":"959_CR25","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis*. Endocr Rev. 1997;18(6):774\u2013800.","journal-title":"Endocr Rev"},{"issue":"6","key":"959_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","volume":"62","author":"A Kumar","year":"2005","unstructured":"Kumar A, Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol. 2005;62(6):644\u20139.","journal-title":"Clin Endocrinol"},{"issue":"1\u20136","key":"959_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0960-0760(99)00044-8","volume":"69","author":"S Franks","year":"1999","unstructured":"Franks S, Gharani N, Gilling-Smith C. Polycystic ovary syndrome: evidence for a primary disorder of ovarian steroidogenesis. J Steroid Biochem Mol Biol. 1999;69(1\u20136):269\u201372.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"959_CR28","first-page":"1158","volume":"79","author":"C Gilling-Smith","year":"1994","unstructured":"Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. The Journal of Clinical Endocrinology & Metabolism. 1994;79(4):1158\u201365.","journal-title":"The Journal of Clinical Endocrinology & Metabolism."},{"issue":"12","key":"959_CR29","doi-asserted-by":"publisher","first-page":"5925","DOI":"10.1210\/jcem.86.12.8088","volume":"86","author":"VL Nelson","year":"2001","unstructured":"Nelson VL, Qin K, Rosenfield RL, Wood JR, Penning TM, Legro RS, et al. The biochemical basis for increased testosterone production in Theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86(12):5925\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"959_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/er.2004-0004","volume":"26","author":"HF Escobar-Morreale","year":"2005","unstructured":"Escobar-Morreale HF, Luque-Ram\u00edrez M, San Mill\u00e1n JL. The molecular-genetic basis of functional Hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26(2):251\u201382.","journal-title":"Endocr Rev"},{"issue":"2018","key":"959_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/7624932","volume":"18","author":"R Dadachanji","year":"2018","unstructured":"Dadachanji R, Shaikh N, Mukherjee S. Genetic variants associated with Hyperandrogenemia in PCOS pathophysiology. Genetics Research International. 2018;18(2018):1\u201312.","journal-title":"Genetics Research International"},{"issue":"9","key":"959_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1056\/NEJM198903023200904","volume":"320","author":"RB Barnes","year":"1989","unstructured":"Barnes RB, Rosenfield RL, Burstein S, Ehrmann DA. Pituitary-ovarian responses to Nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989;320(9):559\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"959_CR33","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016;7(1):10055.","journal-title":"Nat Commun"},{"issue":"16","key":"959_CR34","doi-asserted-by":"publisher","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","volume":"114","author":"ASL Caldwell","year":"2017","unstructured":"Caldwell ASL, Edwards MC, Desai R, Jimenez M, Gilchrist RB, Handelsman DJ, et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2017;114(16):E3334\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"959_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1677\/joe.0.1740001","volume":"174","author":"DH Abbott","year":"2002","unstructured":"Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome - a hypothesis. J Endocrinol. 2002;174(1):1\u20135.","journal-title":"J Endocrinol"},{"key":"959_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.brainres.2010.08.088","volume":"1364","author":"RL Rosenfield","year":"2010","unstructured":"Rosenfield RL, Bordini B. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 2010;1364:186\u201397.","journal-title":"Brain Res"},{"key":"959_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms20225816","volume":"20","author":"P Kurowska","year":"2019","unstructured":"Kurowska P, Mlyczy\u0144ska E, Dawid M, Opydo-Chanek M, Dupont J, Rak A. In vitro effects of Vaspin on porcine Granulosa cell proliferation, cell cycle progression, and apoptosis by activation of GRP78 receptor and several kinase signaling pathways including MAP 3\/1, AKT, and STAT3. Int J Mol Sci. 2019;20:22.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"959_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1507\/endocrj.K10E-330","volume":"58","author":"E Koiou","year":"2011","unstructured":"Koiou E, Tziomalos K, Dinas K, Katsikis I, Kalaitzakis E, Delkos D, et al. The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome. Endocr J. 2011;58(4):237\u201346.","journal-title":"Endocr J"},{"issue":"1","key":"959_CR39","doi-asserted-by":"publisher","first-page":"21328","DOI":"10.1038\/srep21328","volume":"6","author":"M Tang","year":"2016","unstructured":"Tang M, Huang C, Wang YF, Ren PG, Chen L, Xiao TX, et al. CMKLR1 deficiency maintains ovarian steroid production in mice treated chronically with dihydrotestosterone. Sci Rep. 2016;6(1):21328.","journal-title":"Sci Rep"},{"issue":"12","key":"959_CR40","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1080\/09513590.2019.1622087","volume":"35","author":"Y Wang","year":"2019","unstructured":"Wang Y, Huang R, Li X, Zhu Q, Liao Y, Tao T, et al. High concentration of chemerin caused by ovarian hyperandrogenism may lead to poor IVF outcome in polycystic ovary syndrome: a pilot study. Gynecol Endocrinol. 2019;35(12):1072\u20137.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"959_CR41","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1093\/biolre\/ioy096","volume":"99","author":"PDA Lima","year":"2018","unstructured":"Lima PDA, Nivet AL, Wang Q, Chen YA, Leader A, Cheung A, et al. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes\/macrophages\u2020. Biol Reprod. 2018;99(4):838\u201352.","journal-title":"Biol Reprod"},{"issue":"4","key":"959_CR42","doi-asserted-by":"publisher","first-page":"549","DOI":"10.14310\/horm.2002.1649","volume":"14","author":"C Tsatsanis","year":"2015","unstructured":"Tsatsanis C, Dermitzaki E, Avgoustinaki P, Malliaraki N, Mytaras V, Margioris AN. The impact of adipose tissue-derived factors on the hypothalamic-pituitary-gonadal (HPG) axis. Hormones (Athens). 2015;14(4):549\u201362.","journal-title":"Hormones (Athens)"},{"issue":"1","key":"959_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humrep\/deh010","volume":"19","author":"KM Seow","year":"2004","unstructured":"Seow KM, Juan CC, Wu LY, Hsu YP, Yang WM, Tsai YL, et al. Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance. Hum Reprod. 2004;19(1):48\u201353.","journal-title":"Hum Reprod"},{"issue":"8","key":"959_CR44","doi-asserted-by":"publisher","first-page":"4852","DOI":"10.1210\/jc.2004-2152","volume":"90","author":"I Munir","year":"2005","unstructured":"Munir I, Yen HW, Baruth T, Tarkowski R, Azziz R, Magoffin DA, et al. Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: relevance to polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(8):4852\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"959_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1095\/biolreprod.114.120410","volume":"91","author":"L Cloix","year":"2014","unstructured":"Cloix L, Reverchon M, Cornuau M, Froment P, Ram\u00e9 C, Costa C, et al. Expression and regulation of INTELECTIN1 in human granulosa-lutein cells: role in IGF-1-induced steroidogenesis through NAMPT. Biol Reprod. 2014;91(2):50.","journal-title":"Biol Reprod"},{"issue":"5","key":"959_CR46","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1530\/EJE-11-0375","volume":"165","author":"JH Choi","year":"2011","unstructured":"Choi JH, Rhee EJ, Kim KH, Woo HY, Lee WY, Sung KC. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur J Endocrinol. 2011;165(5):789\u201396.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"959_CR47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/cen.12381","volume":"81","author":"B Orlik","year":"2014","unstructured":"Orlik B, Madej P, Owczarek A, Ska\u0142ba P, Chudek J, Olszanecka-Glinianowicz M. Plasma omentin and adiponectin levels as markers of adipose tissue dysfunction in normal weight and obese women with polycystic ovary syndrome. Clin Endocrinol. 2014;81(4):529\u201335.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"959_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tcm.2010.12.002","volume":"20","author":"BK Tan","year":"2010","unstructured":"Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, Diabesity, and cardiovascular disease. Trends Cardiovasc Med. 2010;20(5):143\u20138.","journal-title":"Trends Cardiovasc Med"},{"issue":"2","key":"959_CR49","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5468\/ogs.2018.61.2.253","volume":"61","author":"JJ Kim","year":"2018","unstructured":"Kim JJ, Choi YM, Hong MA, Kim MJ, Chae SJ, Kim SM, et al. Serum visfatin levels in non-obese women with polycystic ovary syndrome and matched controls. Obstet Gynecol Sci. 2018;61(2):253.","journal-title":"Obstet Gynecol Sci"},{"issue":"4","key":"959_CR50","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jpag.2014.08.007","volume":"28","author":"\u00dc G\u00fcm\u00fc\u015f","year":"2015","unstructured":"G\u00fcm\u00fc\u015f \u00dc, G\u00fczel AI, Topcu HO, Timur H, Y\u0131lmaz N, Dan\u0131\u015fman N. Plasma Visfatin levels in adolescents with polycystic ovary syndrome: a prospective case-control study. J Pediatr Adolesc Gynecol. 2015;28(4):249\u201353.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"959_CR51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ejim.2007.05.014","volume":"19","author":"D Panidis","year":"2008","unstructured":"Panidis D, Farmakiotis D, Rousso D, Katsikis I, Delkos D, Piouka A, et al. Plasma visfatin levels in normal weight women with polycystic ovary syndrome. European Journal of Internal Medicine. 2008;19(6):406\u201312.","journal-title":"European Journal of Internal Medicine"},{"issue":"5","key":"959_CR52","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1006\/bbrc.2002.6575","volume":"291","author":"S Taheri","year":"2002","unstructured":"Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, et al. The effects of centrally administered Apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun. 2002;291(5):1208\u201312.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"959_CR53","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/cen.12120","volume":"79","author":"M Olszanecka-Glinianowicz","year":"2013","unstructured":"Olszanecka-Glinianowicz M, Madej P, Nylec M, Owczarek A, Szanecki W, Ska\u0142ba P, et al. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clin Endocrinol. 2013;79(2):238\u201342.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"959_CR54","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/humrep\/des089","volume":"27","author":"M Reverchon","year":"2012","unstructured":"Reverchon M, Cornuau M, Ram\u00e9 C, Guerif F, Roy\u00e8re D, Dupont J. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod. 2012;27(6):1790\u2013800.","journal-title":"Hum Reprod"},{"issue":"6","key":"959_CR55","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.fertnstert.2008.09.008","volume":"92","author":"C Chabrolle","year":"2009","unstructured":"Chabrolle C, Tosca L, Ram\u00e9 C, Lecomte P, Roy\u00e8re D, Dupont J. Adiponectin increases insulin-like growth factor I-induced progesterone and estradiol secretion in human granulosa cells. Fertil Steril. 2009;92(6):1988\u201396.","journal-title":"Fertil Steril"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-00959-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-00959-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T08:05:06Z","timestamp":1655193906000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-00959-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["959"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-00959-6","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out in accordance with the Declaration of Helsinki principles and free informed consent was obtained from all participants. Study protocol was previously approved by the Ethics Committee of the University Hospital of Tours as part of the \u201cPREVADI\u201d and \u201cHAPOFERTI\u201d projects (authorisation number 2016_075).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}